Barron Benedict, Edge Colin, Fenner Sabine, Shrives Harry, Sollis Steven, Whiting Matthew, Valette Damien
Drug Substance Development, GSK, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
Computational Chemistry, GSK, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
Org Lett. 2024 Mar 1;26(8):1533-1538. doi: 10.1021/acs.orglett.3c03694. Epub 2024 Feb 16.
A highly enantioselective organocatalytic aza-Michael addition of 4-nitro-pyrazole to ethyl ()-2,2-difluoro-5-oxopent-3-enoate has been developed. This reaction enabled a concise, four-step, stereoselective synthesis of highly functionalized 3,3-difluoro-4-pyrazolo-piperidine GSK3901383A, a key intermediate for the synthesis of a leucine-rich repeat kinase 2 inhibitor API. Computational analysis provided insight into the steric requirements of the catalytic system, enabling rational selection of a highly selective catalyst.